Arcus Biosciences Inc

RCUS
15,50
0,27 (1,77%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202422:00BWArcus Biosciences to Present New Data from Phase 2 Studies..
23/4/202422:05BWArcus Biosciences to Host Conference Call to Discuss..
09/4/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
26/3/202421:35BWArcus Biosciences Announces New Employment Inducement Grants
11/3/202421:35BWArcus Biosciences Announces New Employment Inducement Grants
28/2/202422:05BWArcus Biosciences to Participate in Two Upcoming Investor..
27/2/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
21/2/202422:53EDGAR2Form S-3ASR - Automatic shelf registration statement of..
21/2/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/2/202422:08EDGAR2Form 8-K - Current report
21/2/202422:05BWArcus Biosciences Reports Fourth-Quarter and Full-Year 2023..
09/2/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
08/2/202400:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/2/202423:00BWArcus Biosciences to Host Conference Call to Discuss..
30/1/202414:17EDGAR2Form 8-K - Current report
30/1/202412:25IHMARKETNEWSArcus Biosciences Stock Jumps 20% on $320M Gilead..
29/1/202423:00BWGilead and Arcus Announce Amended Collaboration and Equity..
26/1/202422:35BWArcus Biosciences Announces New Employment Inducement Grants
26/1/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:00BWData from a Phase 1b Study of Quemliclustat-Based Regimens..
22/12/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:22EDGAR2Form 144 - Report of proposed sale of securities
15/12/202322:21EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
05/12/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00BWExelixis and Arcus Biosciences Announce Clinical Trial..
27/11/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
14/11/202322:00BWArcus Biosciences to Participate in the 6th Annual Evercore..
13/11/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
07/11/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:04EDGAR2Form 8-K - Current report
07/11/202322:01BWArcus Biosciences Reports Third Quarter 2023 Financial..
06/11/202323:00BWGilead and Arcus Announce New Data Showing Encouraging..
24/10/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
17/10/202322:00BWArcus Biosciences to Present Data from Ongoing EDGE-Gastric..
10/10/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
26/9/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
20/9/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202322:53EDGAR2Form 144 - Report of proposed sale of securities
11/9/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
24/8/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
23/8/202315:00BWArcus Biosciences to Participate in Multiple Upcoming..
09/8/202322:35BWArcus Biosciences Announces New Employment Inducement Grants
07/8/202314:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202314:08EDGAR2Form 8-K - Current report
Apertura: 15,27 Min: 15,13 Max: 16,38
Chiusura: 15,23

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network